Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry

BACKGROUND AND PURPOSE: The use of direct oral anticoagulants (DOAC) has increased sharply and DOAC are the oral anticoagulant therapy (OAT) of choice for the majority of patients with newly-diagnosed atrial fibrillation. Intracranial hemorrhage is the most severe adverse event of OAT. Systematic da...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeilschifter, Waltraud, Lindhoff-Last, Edelgard, Alhashim, Ali, Zydek, Barbara, Lindau, Simone, Konstantinides, Stavros, Grottke, Oliver, Nowak-Göttl, Ulrike, von Heymann, Christian, Birschmann, Ingvild, Beyer-Westendorf, Jan, Meybohm, Patrick, Greinacher, Andreas, Herrmann, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059415/
https://www.ncbi.nlm.nih.gov/pubmed/35491419
http://dx.doi.org/10.1186/s42466-022-00183-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059415/
https://www.ncbi.nlm.nih.gov/pubmed/35491419
http://dx.doi.org/10.1186/s42466-022-00183-y

Ejemplares similares